One more milestone: Lupin got USFDA approval for Desoximetasone topical spray

The company has received final approval for its Desoximetasone Topical Spray, 0.25%, 30 ml, 50 ml, and 100 ml from the United States Food and Drug
Administration (USFDA) to market a generic version of Taro Pharmaceuticals USA Inc.'s Topicort Topical Spray, 0.25%.

Desoximetasone Topical Spray is the generic equivalent of Taro Pharmaceuticals USA Inc.'s Topicort Topical Spray, 0.25%.

It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.

Desoximetasone Topical Spray had annual sales of approximately USD 19.5 million in the US, as per IQVIA MAT January 2018 data.